The Triple Bottom Line (TBL) is Novo Nordisk’s way of doing business. We believe that a healthy economy, environment, and society are fundamental to long term business success. Therefore, we operate by taking social, financial, and environmental considerations into account when we make decisions. This ensures we manage our business sustainably and pursue solutions that are in the shared interests of the business and patients, and are in line with societal expectations.

To demonstrate our commitment to TBL, Novo Nordisk is one of only four companies in the world who have incorporated our philosophy into our company bylaws. As a result, the three pillars of TBL – Social Impact, Environmental Responsibility, and Financial Performance inform everything we do and guide every decision we make.

Our commitment to create value through innovation is our greatest contribution to society. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of protein-based products and delivery systems for type 1 and type 2 diabetes care, as well as in other therapeutic areas where we can make a difference.